摘要 |
The present invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds such as (1′R,3′S)-5,7′-dichloro-6′-fluoro-3′-methyl-2′,3′,4′,9′-tetrahydrospiro[indoline-3,1′-pyrido[3,4-b]indol]-2-one and salts and hydrates and solvates thereof. |
申请人 |
NOVARTIS AG |
发明人 |
CROWE, MICHAEL;FOULKES, MICHAEL;FRANCESE, GIANCARLO;GRIMLER, DOMINIQUE;KUESTERS, ERNST;LAUMEN, KURT;LI, YUNZHONG;LIN, CHANGXUE;NAZOR, JOVANA;RUCH, THOMAS;SMITH, DEREK;SONG, SHIWEI;TENG, SHANGJUN |